Alice Macchia

Derio, PV, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1.

Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1.

Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026

Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer.

Secreted spermidine synthase reveals a paracrine role for PGC1α-induced growth suppression in prostate cancer.

Journal: Cell death & disease
Published: October 08, 2024

Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer.

Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer.

Journal: The EMBO journal
Published: May 11, 2023

PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer.

PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer.

Journal: Oncogenesis
Published: March 02, 2021

Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors.

Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors.

Journal: Cell death & disease
Published: August 12, 2020

Genomic and Functional Regulation of TRIB1 Contributes to Prostate Cancer Pathogenesis.

Genomic and Functional Regulation of TRIB1 Contributes to Prostate Cancer Pathogenesis.

Journal: Cancers
Published: August 07, 2020

PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control.

PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control.

Journal: Cancer research
Published: April 17, 2019

Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer.

Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer.

Journal: Cell death & disease
Published: August 10, 2018
Showing 1-8 of 8

Last Updated: 09/26/2026